141 related articles for article (PubMed ID: 8437665)
1. Nerve growth factor receptor expression in medulloblastomas and the potential role of nerve growth factor as a differentiating agent in medulloblastoma cell lines.
Keles GE; Berger MS; Schofield D; Bothwell M
Neurosurgery; 1993 Feb; 32(2):274-80; discussion 280. PubMed ID: 8437665
[TBL] [Abstract][Full Text] [Related]
2. Introduction of nerve growth factor (NGF) receptors into a medulloblastoma cell line results in expression of high- and low-affinity NGF receptors but not NGF-mediated differentiation.
Pleasure SJ; Reddy UR; Venkatakrishnan G; Roy AK; Chen J; Ross AH; Trojanowski JQ; Pleasure DE; Lee VM
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8496-500. PubMed ID: 2172988
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of trk proto-oncogene product in medulloblastoma cells.
Kokunai T; Sawa H; Tamaki N
Neurol Med Chir (Tokyo); 1996 Nov; 36(11):796-804. PubMed ID: 9420431
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules.
Eberhart CG; Kaufman WE; Tihan T; Burger PC
J Neuropathol Exp Neurol; 2001 May; 60(5):462-9. PubMed ID: 11379821
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
6. Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
Sandén E; Dyberg C; Krona C; Visse E; Carén H; Northcott PA; Kool M; Ståhl N; Persson A; Englund E; Johnsen JI; Siesjö P; Darabi A
J Neurooncol; 2015 May; 123(1):1-13. PubMed ID: 25820321
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
8. In vitro properties of a newly established medulloblastoma cell line, MCD-1.
Moore KD; Dillon-Carter O; Conejero C; Poltorak M; Chedid M; Tornatore C; Freed WJ
Mol Chem Neuropathol; 1996; 29(2-3):107-26. PubMed ID: 8971690
[TBL] [Abstract][Full Text] [Related]
9. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
10. Multiple defects of the nerve growth factor receptor in human neuroblastomas.
Azar CG; Scavarda NJ; Reynolds CP; Brodeur GM
Cell Growth Differ; 1990 Sep; 1(9):421-8. PubMed ID: 1963076
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas.
Son EI; Kim IM; Kim DW; Yim MB; Kang YN; Lee SS; Kwon KY; Suh SI; Kwon TK; Lee JJ; Kim DS; Kim SP
Pathol Int; 2003 Feb; 53(2):67-73. PubMed ID: 12588433
[TBL] [Abstract][Full Text] [Related]
12. Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.
Schüller U; Koch A; Hartmann W; Garrè ML; Goodyer CG; Cama A; Sörensen N; Wiestler OD; Pietsch T
Int J Cancer; 2005 Oct; 117(1):82-9. PubMed ID: 15880586
[TBL] [Abstract][Full Text] [Related]
13. A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation.
Lanciotti M; Montaldo PG; Folghera S; Lucarelli E; Cornaglia-Ferraris P; Ponzoni M
Cell Mol Neurobiol; 1992 Jun; 12(3):225-40. PubMed ID: 1358448
[TBL] [Abstract][Full Text] [Related]
14. Expression of nerve growth factor receptor by human primitive neuroectodermal tumors.
Kokunai T; Sawa H; Tatsumi S; Tamaki N
Neurol Med Chir (Tokyo); 1994 Aug; 34(8):523-9. PubMed ID: 7526237
[TBL] [Abstract][Full Text] [Related]
15. A cytomorphological scheme of differentiating neuronal phenotypes in cerebellar medulloblastomas based on immunolocalization of class III beta-tubulin isotype (beta III) and proliferating cell nuclear antigen (PCNA)/cyclin.
Katsetos CD; Krishna L; Frankfurter A; Karkavelas G; Wolfe DE; Valsamis MP; Schiffer D; Vlachos IN; Urich H
Clin Neuropathol; 1995; 14(2):72-81. PubMed ID: 7606900
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.
Su X; Gopalakrishnan V; Stearns D; Aldape K; Lang FF; Fuller G; Snyder E; Eberhart CG; Majumder S
Mol Cell Biol; 2006 Mar; 26(5):1666-78. PubMed ID: 16478988
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation.
Fiorentini C; Facchetti M; Finardi A; Sigala S; Páez-Pereda M; Sher E; Spano P; Missale C
Eur J Endocrinol; 2002 Sep; 147(3):371-9. PubMed ID: 12213675
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns and potential roles of SIRT1 in human medulloblastoma cells in vivo and in vitro.
Ma JX; Li H; Chen XM; Yang XH; Wang Q; Wu ML; Kong QY; Li ZX; Liu J
Neuropathology; 2013 Feb; 33(1):7-16. PubMed ID: 22537175
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism.
Missale C; Losa M; Sigala S; Balsari A; Giovanelli M; Spano PF
Mol Endocrinol; 1996 Mar; 10(3):272-85. PubMed ID: 8833656
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate.
Stockhammer G; Manley GT; Johnson R; Rosenblum MK; Samid D; Lieberman FS
J Neurosurg; 1995 Oct; 83(4):672-81. PubMed ID: 7674018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
